For the quarter ending 2025-09-30, IVP had $182,804 increase in cash & cash equivalents over the period. -$1,326,156 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Depreciation and amortization | 330,498 | 533,795 |
| Amortization of debt issuance costs | 8,969 | 10,208 |
| Amortization of debt discount | 386,325 | 541,620 |
| Amortization of operating right of use assets | 53,418 | 131,140 |
| Stock-based compensation | 0 | 139,274 |
| Issuance of class a common stock for services | 454,600 | 245,100 |
| Loss on debt extinguishment | 689,411 | - |
| Accounts receivable | -154,930 | 142,959 |
| Inventory | 20,623 | -79,659 |
| Prepaid expenses and other current assets | -128,592 | -428,809 |
| Other assets | -5,770 | 0 |
| Accounts payable | -175,173 | -104,065 |
| Accrued expenses | -43,424 | 727,594 |
| Operating lease liabilities | -40,303 | -102,563 |
| Net loss | -2,526,274 | -5,449,604 |
| Loss on debt modification | 689,411 | -689,411 |
| Issuance of class a common stock in connection with general release agreement | 0 | 0 |
| Issuance of class a common stock and pre-funded warrants in connection with commitment shares | 0 | 0 |
| Gain on disposal of business | 0 | - |
| Due from former owners | 0 | 0 |
| Cumulative series a preferred stock dividends payable | 0 | 0 |
| Other assets, net | 0 | - |
| Refundable income tax | 0 | 0 |
| Net cash used in operating activities | -1,282,695 | -2,272,581 |
| Purchase of property and equipment | 43,461 | 32,854 |
| Payment for acquisition of business | 0 | 1,850,000 |
| Net cash used in investing activities | -43,461 | -1,882,854 |
| Proceeds from issuance of class a common stock and warrants, net of issuance costs | 0 | 2,285,521 |
| Proceeds from issuance of class a common stock and pre-funded warrants, net of issuance costs | 0 | 1,571,466 |
| Net proceeds from loans payable | 0 | 1,020,295 |
| Repayments on loans payable | 942,000 | 1,832,400 |
| Proceeds from issuance of convertible series b preferred stock | 2,222,663 | - |
| Proceeds from convertible notes payable | 0 | 250,000 |
| Proceeds from notes payable, net of discount | 0 | 761,190 |
| Proceeds from issuance of convertible series a preferred stock | - | 0 |
| Repayment of notes payable | 271,703 | 730,885 |
| Proceeds from issuance of promissory note | 500,000 | 500,000 |
| Repurchase and cancellation of the class b common stock | 0 | - |
| Proceeds from issuance of convertible series a preferred stock | 0 | - |
| Payments on convertible notes payable | 0 | - |
| Proceeds from exercise of warrants | 0 | - |
| Repayment of convertible debentures | 0 | 0 |
| Net cash provided by financing activities | 1,508,960 | 3,825,187 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 182,804 | -330,248 |
| Cash and cash equivalents at beginning of period | 723,690 | - |
| Cash and cash equivalents at end of period | 576,246 | - |
INSPIRE VETERINARY PARTNERS, INC. (IVP)
INSPIRE VETERINARY PARTNERS, INC. (IVP)